These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 36531487)
21. A study of the natural history of diabetic kidney disease (DKD). Altemtam N; Russell J; El Nahas M Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177 [TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic modification in diabetic kidney disease. Liu Z; Liu J; Wang W; An X; Luo L; Yu D; Sun W Front Endocrinol (Lausanne); 2023; 14():1133970. PubMed ID: 37455912 [TBL] [Abstract][Full Text] [Related]
24. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls. Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707 [TBL] [Abstract][Full Text] [Related]
25. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018. Guo W; Song Y; Sun Y; Du H; Cai Y; You Q; Fu H; Shao L Front Endocrinol (Lausanne); 2022; 13():1071465. PubMed ID: 36561561 [TBL] [Abstract][Full Text] [Related]
26. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease. Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy. Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961 [TBL] [Abstract][Full Text] [Related]
28. Predictive value of ferroptosis-related biomarkers for diabetic kidney disease: a prospective observational study. Wu Y; Sun Y; Wu Y; Zhang K; Chen Y Acta Diabetol; 2023 Apr; 60(4):507-516. PubMed ID: 36633709 [TBL] [Abstract][Full Text] [Related]
29. Diabetic kidney disease in Australia: current burden and future projections. White S; Chadban S Nephrology (Carlton); 2014 Aug; 19(8):450-8. PubMed ID: 24888506 [TBL] [Abstract][Full Text] [Related]
30. Association Between Vitamin D Status and Diabetic Complications in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study in Hunan China. Xiao Y; Wei L; Xiong X; Yang M; Sun L Front Endocrinol (Lausanne); 2020; 11():564738. PubMed ID: 33042022 [No Abstract] [Full Text] [Related]
31. Predictors of intra-hospital mortality in patients with diabetic foot ulcers in Nigeria: data from the MEDFUN study. Adeleye OO; Ugwu ET; Gezawa ID; Okpe I; Ezeani I; Enamino M BMC Endocr Disord; 2020 Aug; 20(1):134. PubMed ID: 32859203 [TBL] [Abstract][Full Text] [Related]
32. Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease. Feng Q; Li Y; Yang Y; Feng J Front Physiol; 2020; 11():578799. PubMed ID: 33123032 [TBL] [Abstract][Full Text] [Related]
33. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Jiang Y; Wang X; Xia L; Fu X; Xu Z; Ran X; Yan L; Li Q; Mo Z; Yan Z; Ji Q; Li Q Wound Repair Regen; 2015; 23(2):222-30. PubMed ID: 25682850 [TBL] [Abstract][Full Text] [Related]
34. [Status Quo and Research Progress in Diagnosis and Treatment of Patients With Diabetes Mellitus and Chronic Kidney Disease]. Dai PY; Yuan QJ; Peng ZZ; Xie YY; Tao LJ; Huang L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):987-996. PubMed ID: 38173112 [TBL] [Abstract][Full Text] [Related]
35. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function". Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L; Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514 [TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E1 for preventing the progression of diabetic kidney disease. Wang H; Deng JL; Yue J; Li J; Hou YB Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745 [TBL] [Abstract][Full Text] [Related]
39. Role of novel biomarker monocyte chemo-attractant protein-1 in early diagnosis & predicting progression of diabetic kidney disease: A comprehensive review. Swaminathan SM; Rao IR; Bhojaraja MV; Attur RP; Nagri SK; Rangaswamy D; Shenoy SV; Nagaraju SP J Natl Med Assoc; 2024 Feb; 116(1):33-44. PubMed ID: 38195327 [TBL] [Abstract][Full Text] [Related]
40. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease? Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]